TNDM
Tandem Diabetes CareFNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
Tandem sustains strong t:slim X2/Control‑IQ adoption, expands recurring software revenue, and improves margins — driving >50% upside as adoption accelerates and investor confidence returns.
Posture
Defensive
Lead driver
Sentiment
What changed
1 setup hits (3d) with net bullish as of 2026-06-03.
What can break
Regulatory setbacks, an adverse recall, or persistent margin pressure from pricing and reimbursement could erase current value and push shares substantially lower (~40%+ decline).
Momentum
7
Value
36
Sentiment
58
Setup hits (3d)
1 · Net Bullish
AI TargetsBase $22.80 · Bull $33.17 · Bear $12.44
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2025-11-27 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Bullish
Target $29.55
Why
Momentum7 · Δ7d +1.4
Value36 · Δ7d -0.0
Sentiment58 · Δ7d -29.9
So what
Weak posture (Net Bullish). Prioritize risk control and patience.
Lead driver: Sentiment · See AI snapshot
Momentum
7
34% active weight
Current posture
7d trendImproving
Δ7d
+1.4
Δ21d
-11.8
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
58
33% active weight
Current posture
7d trendSoftening
Δ7d
-29.9
Δ21d
-25.7
Why this grade
Composite grade F. Momentum 7.1 / Value 36.4 / Sentiment 57.8
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$1.27B
Beta
1.69
Shares Out
67.8M
P/E (TTM) · Derived
-6.2
P/S (TTM)
1.56
P/FCF (TTM) · Derived
-17.55
Rev YoY
+2.2%
EPS YoY
+11.8%
Gross Margin
+53.2%
Op Margin
-19.5%
Net Debt
-$84.59M
Current Ratio
2.44
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology